If “Science has a really serious marketing problem” as Larry Page observed, then life extension technologies face even bigger marketing problems. I am definitely not a marketing expert but realized the problem early on when thinking about the lag-phase period of a robust life extension technology. So I made a short email interview with Dave… Continue reading The marketing problem of life extension technologies
“The best way to predict the future is to invent it.” – said Alan Kay, computer legend in 1971. Recently I had a comment dialogue with Chris on whether state-supported research or industrial business enterprises can (or should) lead to big progress in robust and healthy life extension technologies. Besides the government and corporation coin… Continue reading Biotech DIY for aging/life extension research: the double future?
Looks like the scientist coalition behind healthy life extension is widening. In line with that the question Why was life extension ruled out of the 14 Grand Engineering Challenges? is fading away. Here is an Aubrey de Grey message from my mailbox: All details, including forms for abstract submission and online registration, are at the… Continue reading Understanding Aging Conference in L.A.: de Grey, Conboy, Wagers and many others…
Thanks to Kevin, you can now watch the video too: Colbert: “But if people lived to be a 1000 years old won’t that kill any ability for humans to take risks cause if I’ve known I lived to be a 1000 I am not going to cross the street because you can’t cure being hit… Continue reading Aubrey de Grey on Colbert Report (video) and the housing market in heaven
One strategy (call it Life Extension Gets Personal) to raise awareness for the idea and technology of healthy life extension is to publicly encourage life extension “coming outs” on behalf of mainstream celebrities. In order to get an academic legitimacy for LE (which is one of the most important aim of Pimm) I am interested… Continue reading Craig Venter and the life extension drive: blogterview questions
Embedded on the slideshow below 9 slides of Michael Rose‘s presentation called Slowing and then stopping aging on the SENS3 conference on the 9th of September. (Photos made by me with the iPhone.) Rose’s argument was: Aubrey de Grey’s original SENS proposal is based on the non-evolutionary assumption that aging is a process of accumulating… Continue reading Michael Rose, evolutionary SENS and aging as a loss of adaptation (slides)
You can now pre-order Ending Aging: The Rejuvenation Biotechnologies That Could Reverse Human Aging in Our Lifetime at Amazon written by Aubrey de Grey and Michael Rae which is the most detailed, although popular exposition of the SENS (Strategies for Engineered Negligible Senescence) plan to defeat aging. Aubrey was kind enough to mail me the… Continue reading Content of Ending Aging, Aubrey de Grey’s coming life extension book
Kevin Dewalt, who was blogterviewed by me on his life extension centered life, started his personal blog this week. Excerpts from Kevin’s last post inspired by a lunch with David Gobel, founder and CEO of the Methuselah Foundation: ” The easiest way to simplify something is to look for a reason why it “won’t work”.… Continue reading Kevin Dewalt’s brand new blog
John Schloendorn has a master’s degree in biochemistry at the University of Tuebingen, Germany. Currently he is a graduate student at Arizona State University’s Biodesign Institute, USA. John is heavily involved in the LysoSENS project of the Methuselah Foundation, which aims to remove some intracellular waste products for example via microbe-derived hydrolases targeted to the… Continue reading John Schloendorn, the LysoSENS connection: chat on life extension
Mark Hamalainen is a young PhD student at Cambridge University at the mitochondrion lab of Ian Holt. Mark received a Bachelor of Science Honours degree in biochemistry and computing from Queen’s University in Kingston, Ontario. He also had research training as a visiting scholar at the California Institute of Technology and the Biodesign Institute at… Continue reading Mark Hamalainen, the MitoSENS fellow: blogterview on life extension
Kevin Dewalt is an American technology professional, presently working at a VC. Kevin is a strong life extension supporter. We’ve met online at Baris Karadogan’s blog. I specially liked his “happy argument” for maximum life extension on the psychological level, see answer 3. 1. What is the story of your life extension commitment? When I… Continue reading Kevin Dewalt’s answers: technology professional, lifestyle life extensionist
Dear Reader, if You are stem cell researcher, life scientist, medical doctor, scholar, activist, bloggers, IT professional, venture capitalist, philosopher, economist, politician, decision maker, businessman, biotech- or big pharma manager, plastic surgeon, hairdresser… who support life extension, please answer the questions below and send me to [attilacsordas][at][gmail.com] to get blogterviewed.
Dina Gould Halme and David A. Kessler wrote an article, called FDA Regulation of Stem-Cell–Based Therapies in The New England Journal of Medicine. The key concerns are: i., Stem-cell–based products as therapeutic agents are or could be: biologic products, drugs, devices, xenotransplantation products, human cells, tissues, and cellular and tissue-based products. Human cells, tissues, and… Continue reading FDA Stem Cell Therapy Regulation: the Framework
From Market Wire: University of Arkansas for Medical Sciences Biochemist Dr. Craig Cooney today announced that he is entering the competition to win the Methuselah Mouse Prize (Mprize). Cooney is a epigenetics expert, which is the selective silencing of gene activity along specific segments of a DNA strand mainly through the methylation of the nucleotides.… Continue reading American epigenetics expert in Mprize competition for Methuselah mice